Cargando…

Induction of systemic anti-melanoma immunity through intratumoral TLR-7/8 activation

Detalles Bibliográficos
Autores principales:	Singh, Manisha, Khong, Hiep, Dai, Zhimin, Vasilakos, John P, Hwu, Patrick, Overwijk, Willem W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288567/ http://dx.doi.org/10.1186/2051-1426-2-S3-P176

Ejemplares similares

Induction of potent systemic anti-melanoma immunity through intratumoral CD40 activation and checkpoint blockade
por: Singh, Manisha, et al.
Publicado: (2015)

L-tyrosine is a promising cancer vaccine adjuvant
por: Khong, Hiep, et al.
Publicado: (2015)

Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
por: Smirnov, DV, et al.
Publicado: (2013)

Reversing gp100/IFA-induced impairment of anti-CTLA-4 checkpoint blockade therapy
por: Hailemichael, Yared, et al.
Publicado: (2014)

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
por: Singh, Manisha, et al.
Publicado: (2017)

IL-2 analogues: novel agents circumventing the expansion of T regulatory cells while promoting NK cell activation during IL-2 therapy
por: Sim, Geok Choo, et al.
Publicado: (2013)

Pilot study of intratumoral (IT) cryoablation (cryo) in combination with systemic checkpoint blockade in patients with metastatic melanoma (MM)
por: Kim, Dae Won, et al.
Publicado: (2015)

Adjuvants for peptide-based cancer vaccines
por: Khong, Hiep, et al.
Publicado: (2016)

Intratumoral injections of G100 (synthetic TLR4 agonist) increase trafficking of lentiviral vector-induced antigen-specific CD8 T cells to the tumor microenvironment
por: Albershardt, Tina C, et al.
Publicado: (2015)

TLR-3 and TLR-7/8 ligands indirectly activate Langerhans cells when intradermally injected by triggering the recruitment of inflammatory cells
por: Epaulard, O, et al.
Publicado: (2012)

Intratumoral IL-15 potentiates radiation-induced anti-tumor immunity
por: Pilones, Karsten, et al.
Publicado: (2015)

A "prime-pull" immunotherapy approach using a lentiviral vector and intratumoral TLR4 agonist redirects cytotoxic T cells
por: Albershardt, Tina C, et al.
Publicado: (2014)

Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine
por: Mauldin, Ileana S, et al.
Publicado: (2015)

The role of transcription factor Runx2 in tumor infiltrating T cells
por: Mbofung, Rina, et al.
Publicado: (2013)

Intravenous injection of a modified vaccinia ankara virus induces intratumoral CD8+ lymphocyte infiltration favoring tumor control in an orthotopic tumor model upon combinatorial treatment with a TLR9 agonist
por: Fend, Laetitia, et al.
Publicado: (2014)

Expression of Toll-like receptor (TLR) 2, TLR3, TLR4 and TLR7 is increased in rheumatoid arthritis synovium and regulates cytokine production by dendritic cells upon stimulation of TLR specific pathways
por: Roelofs, MF, et al.
Publicado: (2005)

Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody
por: Sato-Matsushita, Marimo, et al.
Publicado: (2015)

Immediate triggering of 4-1BB co-stimulation during initiation of tumor-infiltrating lymphocyte (TIL) expansion from melanoma tumors accelerates CD8+ T-cell outgrowth and tumor specificity
por: Chacon, Jessica, et al.
Publicado: (2013)

Unc93 homolog B1 restricts systemic lethal inflammation by orchestrating TLR7 and TLR9 response
por: Fukui, Ryutaro, et al.
Publicado: (2012)

Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
por: Mullins, Stefanie R., et al.
Publicado: (2019)

Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment
por: Andtbacka, Robert HI, et al.
Publicado: (2015)

Intratumoral injection of STING ligand promotes abscopal effect
por: Baird, Jason R, et al.
Publicado: (2014)

Metabolic insufficiency underlies intratumoral cytotoxic T cell dysfunction
por: Gupta, Tushar, et al.
Publicado: (2015)

Intratumoral delivery of TransCon(™) TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine induction
por: Zúñiga, Luis Alejandro, et al.
Publicado: (2022)

Gene expression analysis of tumors demonstrates an induction of Th1 type immune response following intratumoral administration of ONCOS-102 in refractory solid tumor patients
por: Majumder, Mamun, et al.
Publicado: (2014)

TLR7/9 antagonist reduces HIV-1-induced immune activation
por: Chang, J, et al.
Publicado: (2012)

Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
por: Sharma, Meenu, et al.
Publicado: (2020)

Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
por: Jensen, Simon S, et al.
Publicado: (2013)

HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells
por: Chung, NP, et al.
Publicado: (2012)

TLR-9, but not TLR-2, TLR-3 and TLR-4, is upregulated on peripheral blood mononuclear cells of patients with active systemic lupus erythematosus
por: Papadimitraki, ED, et al.
Publicado: (2005)

Bim and PD-1 identify effector CD8 T cells responsive to anti-PD-1 therapy in metastatic melanoma patients
por: Dronca, Roxana, et al.
Publicado: (2015)

High frequency CD8+PD-1+ TCR clonotypes isolated from fresh melanomas display anti-tumor activity
por: Anna, Pasetto, et al.
Publicado: (2015)

Precise determination of toll-like receptor (TLR) 7 expression in multiple human tumor types
por: Cumberbatch, Marie, et al.
Publicado: (2014)

The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)
por: Wittkowski, H, et al.
Publicado: (2008)

TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
por: Lu, Hailing, et al.
Publicado: (2013)

Comparison of immune modulation by TLR8 agonist vtx-2337 (motolimod) in cancer patients and healthy volunteers
por: Dietsch, Greg, et al.
Publicado: (2014)

You can run but you can't hide: tracking T cells in metastatic melanoma patients treated with tumor-infiltrating lymphocytes
por: Haymaker, Cara, et al.
Publicado: (2015)

Novel drug delivery system using acoustic control of intratumoral drug distribution
por: Kawabata, Ken-ichi, et al.
Publicado: (2015)

Accumulation of MDSC subsets in renal cell carcinoma correlates with grade and progression free survival, and is associated with intratumoral expression of IL-1β, IL-8 and CXCL5
por: Najjar, Yana G, et al.
Publicado: (2014)

Single-cell motility and gene expression signature as predictors of the overall survival of act in melanoma patients
por: Martinez-Paniagua, Melisa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d1rn4c8bbcprqjjaa2ro0pg471